Sanarus Medical Company

Sanarus Medical, Inc. develops and markets minimally invasive devices for the diagnosis and treatment of breast tumors. It offers Visica treatment system for cryoablation of breast fibroadenomas
Technology:
Biomarkers of Female Cancers
Industry:
Diagnostics
Headquarters:
Pleasanton, California, United States
Founded Date:
1999-01-01
Funding Status:
Series E
Investors Number:
8
Total Funding:
$71 M
Estimated Revenue:
$50M to $100M
Register and Claim Ownership